Larry PARTAIN,Mingshan SUN,Edward J. SEPPI,Raisa PAVLYUCHKOVA,Arundhuti GANGULY,Stavros PRIONAS,James E. CLAYTON,Nicolas PRIONAS,John M. BOONE
申请号：
US13623103
公开号：
US20130071334A1
申请日:
2012.09.19
申请国别(地区):
US
年份:
2013
代理人:
摘要：
Techniques described herein generally relate to identifying, assessing, and managing cancer diseases. Some example methods may include constructing one or more quantitative metrics for the cancer disease in a selected population of other patients retrieved during the scheduling interval, acquiring a first set of numeric biomarker data for the patient before having placed a biomarker in the patient, acquiring a second set of numeric biomarker data for the patient after having placed the biomarker in the patient, identifying one or more nodules from the first set of numeric biomarker data and the second set of numeric biomarker data, wherein each of the one or more nodules is characterized by a mean numeric biomarker difference value derived from the first set of numeric biomarker data and the second set of numeric biomarker data, and predicting quantitative and objective risk for the one or more nodules based on the mean numeric biomarker difference value and at least one of the one or more quantitative metrics.
